An ICON Whitepaper endorsed by the PCMG
Gather tips and checklists for making the move to decentralised clinical trials.
This whitepaper explores:
Understanding the different models: traditional, hybrid and decentralised
Factors to consider when choosing the best model for your trial
Using the operational ecosystem as a framework
Regulatory aspects and considerations
Step by step approach and checklists for including wearables and sensors
Case study demonstrating how a hybrid approach can decrease burden for the patient and the site
For more information on decentralised trials or to speak with one of our experts, please contact us.
Enquiry formICON invited senior biopharma executives to discuss how decentralised and hybrid clinical trial models can provide increased resilience and how their respective organisations are currently or likely to address diversity and inclusion in clinical trials going forward. Our summary report outlines how these executives see the opportunity in the developments of 2020, paving the way for continuous improvements into the future.
Read the summary report